NYSEARCA:PJP Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News $117.60 -0.95 (-0.80%) As of 07/13/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock About Invesco Pharmaceuticals ETF (NYSEARCA:PJP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PJP alerts:Sign Up Key Stats Today's Range$117.20▼$118.6650-Day Range$105.05▼$122.2452-Week Range$80.63▼$122.69Volume424,578 shsAverage Volume34,423 shsMarket Capitalization$353.98 millionAssets Under Management$357.90 millionDividend Yield0.90%Net Expense Ratio0.56%Aggregate RatingModerate Buy ETF Overview PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC. Read More Invesco Pharmaceuticals ETF ExpensesTypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.57%0.51%0.53%Other Expenses0.06%0.47%0.55%0.58%0.55%Total Expense0.56%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.71%-0.64%-0.70%-0.62%Net Expense0.56%0.59%0.63%0.58%0.60% Receive PJP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PJP ETF News HeadlinesInvesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?July 9, 2026 | finance.yahoo.comIHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?July 5, 2026 | fool.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.July 14 at 1:00 AM | Porter & Company (Ad)State Street Health Care ETF Tops Invesco Pharma on Cost and SizeJuly 4, 2026 | fool.comInvesco Pharmaceuticals ETF declares quarterly distribution of $0.2733June 24, 2026 | msn.comBiotech Investors Are Tuning Out the MAHA ChaosMay 20, 2026 | wsj.comSee More Headlines PJP ETF - Frequently Asked Questions How have PJP shares performed this year? Invesco Pharmaceuticals ETF's stock was trading at $104.54 at the start of the year. Since then, PJP stock has increased by 12.5% and is now trading at $117.60. Who are Invesco Pharmaceuticals ETF's major shareholders? Invesco Pharmaceuticals ETF's top institutional shareholders include Trilogy Capital Inc. (0.51%). How do I buy shares of Invesco Pharmaceuticals ETF? Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Pharmaceuticals ETF investors own include NVIDIA (NVDA), Meta Platforms (META), Walt Disney (DIS), Affirm (AFRM), Advanced Micro Devices (AMD), Netflix (NFLX) and Pfizer (PFE). Fund Details IssuerInvesco Fund NameInvesco Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceutical Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings30 Fund Statistics Assets Under Management$357.90 million Average Daily Volume$15.06 thousand Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume6 Put Options6 Call Options0 Short Interest12,241 shs Miscellaneous Outstanding Shares3,010,000Beta0.45 Creation Unit10,000 Creation Fee$500.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 PJP HoldingsAbbVie (NYSE:ABBV)Holding Weight: 5.62%Eli Lilly and Company (NYSE:LLY)Holding Weight: 5.30%Johnson & Johnson (NYSE:JNJ)Holding Weight: 5.29%Abbott Laboratories (NYSE:ABT)Holding Weight: 5.18%Amgen (NASDAQ:AMGN)Holding Weight: 5.12%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 4.97%Gilead Sciences (NASDAQ:GILD)Holding Weight: 4.55%Pfizer (NYSE:PFE)Holding Weight: 4.31%Corcept Therapeutics (NASDAQ:CORT)Holding Weight: 4.01%Ligand Pharmaceuticals (NASDAQ:LGND)Holding Weight: 3.60%Full Holdings DetailsPJP Sector ExposurePJP Industry Exposure This page (NYSEARCA:PJP) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour money is changingPorter Stansberry - who warned readers about Fannie Mae in 2006, called gold in 2008, and predicted COVID-era ...Porter & Company | SponsoredThe $5 company SpaceX can’t survive withoutThe investors who got rich on AI didn't all buy Nvidia. Some bought ASML, the company that makes the machines ...Traders Agency | SponsoredTrump Set to Unleash 219-Year-Old “Super Weapon” on U.S. SoilFour-time U.S. Presidential advisor Jim Rickards is warning of a political move he calls 'The Trump Supremacy'...Paradigm Press | Sponsored60 years. Zero competitors.One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PJP Stock Alerts